Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 88.
Article
Abdel-Mannan, O;
Cortese, R;
Wassmer, E;
Hemingway, C;
Thompson, A;
Brownlee, W;
Ciccarelli, O;
(2020)
Primary progressive multiple sclerosis presenting under the age of 18 years: fact or fiction?
Multiple Sclerosis Journal
(In press).
|
Abdel-Mannan, O;
Eyre, M;
Löbel, U;
Bamford, A;
Eltze, C;
Hameed, B;
Hemingway, C;
(2020)
Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children.
JAMA Neurology
, 77
(11)
pp. 1440-1445.
10.1001/jamaneurol.2020.2687.
|
Abdel-Mannan, O;
Sutcliffe, AG;
(2020)
A national surveillance study of childhood epilepsy mortality in the UK and Ireland.
European Journal of Neurology
, 27
(2)
pp. 327-333.
10.1111/ene.14081.
|
Armangue, T;
Capobianco, M;
de Chalus, A;
Laetitia, G;
Deiva, K;
E.U. paediatric MOG consortium;
(2020)
E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European Journal of Paediatric Neurology
, 29
pp. 22-31.
10.1016/j.ejpn.2020.11.001.
|
Arrambide, G;
Iacobaeus, E;
Amato, MP;
Derfuss, T;
Vukusic, S;
Hemmer, B;
Brundin, L;
... 2018 ECTRIMS Focused Workshop Group; + view all
(2020)
Aggressive multiple sclerosis (2): Treatment.
Multiple Sclerosis Journal
, 26
(9)
pp. 1045-1063.
10.1177/1352458520924595.
|
Auguste, P;
Colquitt, J;
Connock, M;
Loveman, E;
Court, R;
Ciccarelli, O;
Counsell, C;
(2020)
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PharmacoEconomics
, 38
pp. 527-538.
10.1007/s40273-020-00889-4.
|
Baumann, M;
Bartels, F;
Finke, C;
Adamsbaum, C;
Hacohen, Y;
Rostásy, K;
E.U. paediatric MOG consortium;
(2020)
E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European Journal of Paediatric Neurology
, 29
pp. 14-21.
10.1016/j.ejpn.2020.10.002.
|
Brownlee, W;
Bourdette, D;
Broadley, S;
Killestein, J;
Ciccarelli, O;
(2020)
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
Neurology
10.1212/WNL.0000000000009507.
(In press).
|
Brownlee, WJ;
(2020)
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?
Multiple Sclerosis Journal
, 26
(10)
p. 1267.
10.1177/1352458520948211.
|
Bruijstens, Arlette L;
Breu, Markus;
Wendel, Eva-Maria;
Wassmer, Evangeline;
Lim, Ming;
Neuteboom, Rinze F;
Wickström, Ronny;
... Rostasy, K; + view all
(2020)
E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European Journal of Paediatric Neurology
, 29
pp. 32-40.
10.1016/j.ejpn.2020.10.007.
|
Bruijstens, Arlette L;
Lechner, Christian;
Flet-Berliac, Lorraine;
Deiva, Kumaran;
Neuteboom, Rinze F;
Hemingway, Cheryl;
Wassmer, Evangeline;
... Rostasy, K; + view all
(2020)
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European Journal of Paediatric Neurology
, 29
pp. 2-13.
10.1016/j.ejpn.2020.10.006.
|
Bruijstens, AL;
Wendel, EM;
Lechner, C;
Bartels, F;
Finke, C;
Breu, M;
Flet-Berliac, L;
... Neuteboom, RF; + view all
(2020)
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European Journal of Paediatric Neurology
10.1016/j.ejpn.2020.10.005.
(In press).
|
Calvi, A;
Haider, L;
Prados, F;
Tur, C;
Chard, D;
Barkhof, F;
(2020)
In vivo imaging of chronic active lesions in multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458520958589.
(In press).
|
Castellazzi, G;
Cuzzoni, MG;
Cotta Ramusino, M;
Martinelli, D;
Denaro, F;
Ricciardi, A;
Vitali, P;
... Gandini Wheeler-Kingshott, CAM; + view all
(2020)
A Machine Learning Approach for the Differential Diagnosis of Alzheimer and Vascular Dementia Fed by MRI Selected Features.
Frontiers in Neuroinformatics
, 14
, Article 25. 10.3389/fninf.2020.00025.
|
Catarino, CB;
von Livonius, B;
Priglinger, C;
Banik, R;
Matloob, S;
Tamhankar, MA;
Castillo, L;
... Klopstock, T; + view all
(2020)
Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
Journal of Neuro-Ophthalmology
, 40
(4)
pp. 558-565.
10.1097/WNO.0000000000001023.
|
Charalambous, T;
Clayden, JD;
Powell, E;
Prados, F;
Tur, C;
Kanber, B;
Chard, D;
... Toosy, AT; + view all
(2020)
Disrupted principal network organisation in multiple sclerosis relates to disability.
Scientific Reports
, 10
, Article 3620. 10.1038/s41598-020-60611-4.
|
Chataway, J;
De Angelis, F;
Connick, P;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
... MS-SMART Investigators; + view all
(2020)
Efficacy of three neuroprotective drugs in secondary
progressive multiple sclerosis (MS-SMART): a phase 2b,
multiarm, double-blind, randomised placebo-controlled trial.
The Lancet Neurology
10.1016/S1474-4422(19)30485-5.
(In press).
|
Chung, KK;
Altmann, D;
Barkhof, F;
Miszkiel, K;
Brex, PA;
O'Riordan, J;
Ebner, M;
... Chard, DT; + view all
(2020)
A thirty year clinical and MRI observational study of multiple sclerosis and clinically isolated syndromes.
Annals of Neurology
, 87
(1)
pp. 63-74.
10.1002/ana.25637.
|
Ciccarelli, O;
Cohen, JA;
Thompson, A;
(2020)
Response of the multiple sclerosis community to COVID-19.
Multiple Sclerosis Journal
, 26
(10)
pp. 1134-1136.
10.1177/1352458520948748.
|
Cole, JH;
Raffel, J;
Friede, T;
Eshaghi, A;
Brownlee, WJ;
Chard, D;
De Stefano, N;
... MAGNIMS study group; + view all
(2020)
Longitudinal assessment of multiple sclerosis with the brain-age paradigm.
Annals of Neurology
, 88
(1)
pp. 93-105.
10.1002/ana.25746.
|
Collorone, S;
Toosy, A;
(2020)
Clinical commentary on the broadening spectrum of myelin oligodendrocyte glycoprotein-associated disorder (MOGAD).
Multiple Sclerosis Journal
10.1177/1352458520933539.
(In press).
|
Cortese, R;
Tur, C;
Prados, F;
Schneider, T;
Kanber, B;
Moccia, M;
Wheeler-Kingshott, CAMG;
... Ciccarelli, O; + view all
(2020)
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458519900971.
(In press).
|
Cree, BAC;
Cutter, G;
Wolinsky, JS;
Freedman, MS;
Comi, G;
Giovannoni, G;
Hartung, HP;
... Perminder, B; + view all
(2020)
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet Neurology
, 19
(12)
pp. 988-997.
10.1016/S1474-4422(20)30347-1.
|
Cunniffe, N;
Vuong, KA;
Ainslie, D;
Baker, D;
Beveridge, J;
Bickley, S;
Camilleri, P;
... Coles, A; + view all
(2020)
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-324286.
(In press).
|
De Angelis, F;
Connick, P;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
Stutters, J;
... Chataway, J; + view all
(2020)
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT.
Efficacy and Mechanism Evaluation
, 7
(3)
pp. 1-72.
10.3310/eme07030.
|
de Sitter, A;
Verhoeven, T;
Burggraaff, J;
Liu, Y;
Simoes, J;
Ruggieri, S;
Palotai, M;
... MAGNIMS Study Group; + view all
(2020)
Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohort.
Journal of Neurology
10.1007/s00415-020-10023-1.
(In press).
|
de Sitter, A;
Visser, M;
Brouwer, I;
Cover, KS;
van Schijndel, RA;
Eijgelaar, RS;
Muller, DMJ;
... on behalf of the MAGNIMS Study Group and Alzheimer's Disease Neu; + view all
(2020)
Facing privacy in neuroimaging: Removing facial features degrades performance of image analysis methods.
European Radiology
, 30
pp. 1062-1074.
10.1007/s00330-019-06459-3.
|
Desai, RA;
Davies, AL;
Del Rossi, N;
Tachrount, M;
Dyson, A;
Gustavson, B;
Kaynezhad, P;
... Smith, KJ; + view all
(2020)
Nimodipine reduces dysfunction and demyelination in models of multiple sclerosis.
Annals of Neurology
, 88
(1)
pp. 123-136.
10.1002/ana.25749.
|
Eshaghi, A;
(2020)
First approved treatment in children with multiple sclerosis slows brain atrophy.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(5)
p. 454.
10.1136/jnnp-2019-322519.
|
Eshaghi, A;
(2020)
Towards an objective classification of multiple sclerosis.
[Editorial comment].
Multiple Sclerosis Journal
10.1177/1352458520975325.
(In press).
|
Filippi, M;
Preziosa, P;
Barkhof, F;
Chard, DT;
De Stefano, N;
Fox, RJ;
Gasperini, C;
... Rocca, MA; + view all
(2020)
Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.
JAMA Neurology
10.1001/jamaneurol.2020.4689.
(In press).
|
Geraldes, R;
Juryńczyk, M;
Dos Passos, G;
Prichler, A;
Chung, K;
Hagens, M;
Ruggieri, S;
... MAGNIMS study group; + view all
(2020)
Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(4)
pp. 388-391.
10.1136/jnnp-2019-322369.
|
Geraldes, R;
Juryńczyk, M;
Dos Passos, GR;
Pichler, A;
Chung, K;
Hagens, M;
Ruggieri, S;
... MAGNIMS study group, .; + view all
(2020)
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.
Multiple Sclerosis Journal
10.1177/1352458520943777.
(In press).
|
Gomez, C;
Kanber, B;
Eshaghi, A;
Altmann, DR;
Khaleeli, Z;
Prados Carrasco, F;
Ourselin, S;
... Ciccarelli, O; + view all
(2020)
Clinical relevance of cortical network dynamics in early primary progressive MS.
Multiple Sclerosis Journal
, 26
(4)
pp. 442-456.
10.1177/1352458519831400.
|
Goodkin, O;
Pemberton, HG;
Vos, SB;
Prados, F;
Das, RK;
Moggridge, J;
De Blasi, B;
... Barkhof, F; + view all
(2020)
Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis.
European Radiology
10.1007/s00330-020-07075-2.
(In press).
|
Graham, NSN;
Jolly, A;
Zimmerman, K;
Bourke, NJ;
Scott, G;
Cole, JH;
Schott, JM;
(2020)
Diffuse axonal injury predicts neurodegeneration after moderate–severe traumatic brain injury.
Brain
, 143
(12)
pp. 3685-3698.
10.1093/brain/awaa316.
|
Grussu, F;
Battiston, M;
Veraart, J;
Schneider, T;
Cohen-Adad, J;
Shepherd, TM;
Alexander, DC;
... Gandini Wheeler-Kingshott, CAM; + view all
(2020)
Multi-parametric quantitative in vivo spinal cord MRI with unified signal readout and image denoising.
Neuroimage
, 217
, Article 116884. 10.1016/j.neuroimage.2020.116884.
|
Hacohen, Y;
Banwell, B;
Ciccarelli, O;
(2020)
What does first-line therapy mean for paediatric multiple sclerosis in the current era?
Multiple Sclerosis Journal
10.1177/1352458520937644.
(In press).
|
Hacohen, Y;
Marignier, R;
(2020)
Myelin oligodendrocyte glycoprotein antibodies associated disease: how important are B cells?
Developmental Medicine & Child Neurology
, 62
(3)
p. 273.
10.1111/dmcn.14370.
|
He, Anna;
Merkel, Bernd;
Brown, James William L;
Ryerson, Lana Zhovits;
Kister, Ilya;
Malpas, Charles B;
Sharmin, Sifat;
... Kalincik, Tomas; + view all
(2020)
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
Lancet Neurology
, 19
(4)
pp. 307-316.
10.1016/S1474-4422(20)30067-3.
|
Hooper, C;
Sainz-Fuertes, R;
Lynham, S;
Hye, A;
Killick, R;
Warley, A;
Bolondi, C;
... Lovestone, S; + view all
(2020)
Correction to: Wnt3a induces exosome secretion from primary cultured rat microglia.
[Corrigendum].
BMC Neuroscience
, 21
(1)
, Article 10. 10.1186/s12868-020-0558-9.
|
Iacobaeus, E;
Arrambide, G;
Pia Amato, M;
Derfuss, T;
Vukusic, S;
Hemmer, B;
Tintore, M;
... 2018 ECTRIMS Focused Workshop Group; + view all
(2020)
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
Multiple Sclerosis Journal
, 26
(9)
pp. 1031-1044.
10.1177/1352458520925369.
|
James, E;
Young, CA;
Gibbons, EL;
Shueb, A;
Tur, C;
(2020)
Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis.
Cochrane Database of Systematic Reviews
, 2020
(4)
, Article CD013599. 10.1002/14651858.CD013599.
|
Kanber, B;
Ruffle, J;
Cardoso, J;
Ourselin, S;
Ciccarelli, O;
(2020)
Neurosense: deep sensing of full or near-full coverage head/brain scans in human magnetic resonance imaging.
Neuroinformatics
, 18
pp. 333-336.
10.1007/s12021-019-09442-x.
|
Kim, M;
Kujawa, A;
Battiston, M;
Demetriou, E;
Schneider, T;
Collorone, S;
Tur, C;
... Golay, X; + view all
(2020)
Translating pH‐sensitive PROgressive saturation for QUantifying Exchange rates using Saturation Times (PRO‐QUEST) MRI to a 3T clinical scanner.
Magnetic Resonance in Medicine
, 84
(4)
pp. 1734-1746.
10.1002/mrm.28229.
|
Leutritz, T;
Seif, M;
Helms, G;
Samson, RS;
Curt, A;
Freund, P;
Weiskopf, N;
(2020)
Multiparameter mapping of relaxation (R1,R2*), proton density and magnetization transfer saturation at3 T: A multicenter dual-vendor reproducibility and repeatability study.
Human Brain Mapping
10.1002/hbm.25122.
(In press).
|
Licht-Mayer, S;
Campbell, GR;
Canizares, M;
Mehta, AR;
Gane, AB;
McGill, K;
Ghosh, A;
... Mahad, DJ; + view all
(2020)
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.
Acta Neuropathologica
, 140
pp. 143-167.
10.1007/s00401-020-02179-x.
|
Liu, W;
Taso, O;
Wang, R;
Bayram, S;
Graham, AC;
Garcia-Reitboeck, P;
Mallach, A;
... Salih, DA; + view all
(2020)
Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions.
Human Molecular Genetics
10.1093/hmg/ddaa209.
(In press).
|
Lorenzi, RM;
Palesi, F;
Castellazzi, G;
Vitali, P;
Anzalone, N;
Bernini, S;
Cotta Ramusino, M;
... Gandini Wheeler-Kingshott, CAM; + view all
(2020)
Unsuspected Involvement of Spinal Cord in Alzheimer Disease.
Frontiers in Cellular Neuroscience
, 14
, Article 6. 10.3389/fncel.2020.00006.
|
Merino, JG;
Worrall, BB;
Baskin, PK;
Ciccarelli, O;
(2020)
Neurology's commitment to address gender bias in neurology journals.
Neurology
, 95
(11)
pp. 465-466.
10.1212/WNL.0000000000010539.
|
Moccia, M;
de Pavert, SV;
Eshaghi, A;
Haider, L;
Pichat, J;
Yiannakas, M;
Ourselin, S;
... Ciccarelli, O; + view all
(2020)
Pathologic correlates of the magnetization transfer ratio in multiple sclerosis.
Neurology
, 95
(22)
E2965-E2976.
10.1212/WNL.0000000000010909.
|
Moccia, M;
Valsecchi, N;
Ciccarelli, O;
Van Schijndel, R;
Barkhof, F;
Prados, F;
(2020)
Spinal cord atrophy in a primary progressive multiple sclerosis trial: Improved sample size using GBSI.
NeuroImage: Clinical
, 28
10.1016/j.nicl.2020.102418.
|
Moore, L;
Eggleton, P;
Smerdon, G;
Newcombe, J;
Holley, JE;
Gutowski, NJ;
Smallwood, M;
(2020)
Engagement of people with multiple sclerosis to enhance research into the physiological effect of hyperbaric oxygen therapy.
Multiple Sclerosis and Related Disorders
, 43
, Article 102084. 10.1016/j.msard.2020.102084.
|
Ning, L;
Bonet-Carne, E;
Grussu, F;
Sepehrband, F;
Kaden, E;
Veraart, J;
Blumberg, SB;
... Tax, CMW; + view all
(2020)
Cross-scanner and cross-protocol multi-shell diffusion MRI data harmonization: algorithms and results.
NeuroImage
, 221
, Article 117128. 10.1016/j.neuroimage.2020.117128.
|
Palesi, F;
Lorenzi, RM;
Casellato, C;
Ritter, P;
Jirsa, V;
Gandini Wheeler-Kingshott, CAM;
D’Angelo, E;
(2020)
The Importance of Cerebellar Connectivity on Simulated Brain Dynamics.
Frontiers in Cellular Neuroscience
, 14
, Article 250. 10.3389/fncel.2020.00240.
|
Paolilo, RB;
Hacohen, Y;
Yazbeck, E;
Armangue, T;
Bruijstens, A;
Lechner, C;
Apostolos-Pereira, SL;
... Deiva, K; + view all
(2020)
Treatment and outcome of aquaporin-4 antibody-positive NMOSD: A multinational pediatric study.
Neurology: Neuroimmunology & NeuroInflammation
, 7
(5)
pp. 1-12.
10.1212/NXI.0000000000000837.
|
Paskevicius, T;
Jung, J;
Pujol, M;
Eggleton, P;
Qin, W;
Robinson, A;
Gutowski, N;
... Agellon, LB; + view all
(2020)
The Fabp5/calnexin complex is a prerequisite for sensitization of mice to experimental autoimmune encephalomyelitis.
The FASEB Journal
, 34
(12)
pp. 16662-16675.
10.1096/fj.202001539RR.
|
Pizzarotti, B;
Palesi, F;
Vitali, P;
Castellazzi, G;
Anzalone, N;
Alvisi, E;
Martinelli, D;
... Wheeler-Kingshott, CAMG; + view all
(2020)
Frontal and Cerebellar Atrophy Supports FTSD-ALS Clinical Continuum.
Frontiers In Aging Neuroscience
, 12
, Article 593526. 10.3389/fnagi.2020.593526.
|
Prados, F;
Moccia, M;
Johnson, A;
Yiannakas, M;
Grussu, F;
Cardoso, MJ;
Ciccarelli, O;
... Wheeler-Kingshott, C; + view all
(2020)
Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy.
Neuroimage
, 209
, Article 116489. 10.1016/j.neuroimage.2019.116489.
|
Prudencio, M;
Humphrey, J;
Pickles, S;
Brown, A-L;
Hill, SE;
Kachergus, J;
Shi, J;
... Petrucelli, L; + view all
(2020)
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.
Journal of Clinical Investigation
10.1172/JCI139741.
(In press).
|
Redolfi, A;
De Francesco, S;
Palesi, F;
Galluzzi, S;
Muscio, C;
Castellazzi, G;
Tiraboschi, P;
... D'Angelo, E; + view all
(2020)
Medical Informatics Platform (MIP): A Pilot Study Across Clinical Italian Cohorts.
Frontiers in Neurology
, 11
, Article 1021. 10.3389/fneur.2020.01021.
|
Rossor, T;
Benetou, C;
Wright, S;
Duignan, S;
Lascelles, K;
Robinson, R;
Das, K;
... Hacohen, Y; + view all
(2020)
Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis.
Multiple Sclerosis Journal
, 26
(3)
pp. 333-342.
10.1177/1352458518823486.
|
Sastre-Garriga, J;
Pareto, D;
Battaglini, M;
Rocca, MA;
Ciccarelli, O;
Enzinger, C;
Wuerfel, J;
... Rovira, À; + view all
(2020)
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
Nature Reviews Neurology
, 16
pp. 171-182.
10.1038/s41582-020-0314-x.
|
Smethurst, P;
Risse, E;
Tyzack, GE;
Mitchell, JS;
Taha, DM;
Chen, Y-R;
Newcombe, J;
... Patani, R; + view all
(2020)
Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Brain
, 143
(2)
pp. 430-440.
10.1093/brain/awz419.
|
Solanky, BS;
John, NA;
DeAngelis, F;
Stutters, J;
Prados, F;
Schneider, T;
Parker, RA;
... MS-SMART Investigators, ./; + view all
(2020)
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
American Journal of Neuroradiology
10.3174/ajnr.A6809.
(In press).
|
Solanky, BS;
Prados, F;
Tur, C;
Yiannakas, MC;
Kanber, B;
Cawley, N;
Brownlee, W;
... Gandini Wheeler-Kingshott, CAM; + view all
(2020)
Sodium in the Relapsing–Remitting Multiple Sclerosis Spinal Cord: Increased Concentrations and Associations With Microstructural Tissue Anisotropy.
Journal of Magnetic Resonance Imaging
10.1002/jmri.27201.
(In press).
|
Strik, M;
Chard, DT;
Dekker, I;
Meijer, KA;
Eijlers, AJ;
Pardini, M;
Uitdehaag, BM;
... Schoonheim, MM; + view all
(2020)
Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458520966292.
(In press).
|
Surana, S;
Rossor, T;
Hassell, J;
Boyd, S;
D'Arco, F;
Aylett, S;
Bhate, S;
... Hacohen, Y; + view all
(2020)
Diagnostic algorithm for children presenting with epilepsia partialis continua.
Epilepsia
, 61
(10)
pp. 2224-2233.
10.1111/epi.16650.
|
Thompson, A;
Ciccarelli, O;
(2020)
Towards treating progressive multiple sclerosis.
Nature Reviews Neurology
, 16
pp. 589-590.
10.1038/s41582-020-00421-4.
|
Tyzack, GE;
Manferrari, G;
Newcombe, J;
Luscombe, NM;
Luisier, R;
Patani, R;
(2020)
Paraspeckle components NONO and PSPC1 are not mislocalized from motor neuron nuclei in sporadic ALS.
Brain
, 143
(8)
, Article e66. 10.1093/brain/awaa205.
|
Ulivi, L;
Kanber, B;
Prados, F;
Davagnanam, I;
Merwick, A;
Chan, E;
Williams, F;
... Werring, DJ; + view all
(2020)
White matter integrity correlates with cognition and disease severity in Fabry disease.
Brain
, 143
(11)
pp. 3331-3342.
10.1093/brain/awaa282.
|
Varley, James A;
Andersson, Magnus;
Grant, Eleanor;
Berretta, Antonio;
Zandi, Michael S;
Bondet, Vincent;
Duffy, Darragh;
... Irani, Sarosh R; + view all
(2020)
Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.
Annals of Neurology
, 88
(6)
pp. 1244-1250.
10.1002/ana.25908.
|
Vitali, P;
Pan, M;
Palesi, F;
Germani, G;
Faggioli, A;
Anzalone, N;
Francaviglia, P;
... Wheeler-Kingshott, CAMG; + view all
(2020)
Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease.
Radiology
, 296
(2)
pp. 401-410.
10.1148/radiol.2020191235.
|
Wardlow, J;
Benveniste, H;
Nedergaard, M;
Zlokovic, B;
Mestre, H;
Lee, H;
Doubal, F;
... Black, S; + view all
(2020)
Perivascular spaces in the brain: anatomy, physiology and pathology.
Nature Reviews Neurology
, 16
pp. 137-153.
10.1038/s41582-020-0312-z.
|
Whittam, DH;
Cobo-Calvo, A;
Lopez-Chiriboga, AS;
Pardo, S;
Gornall, M;
Cicconi, S;
Brandt, A;
... Jacob, A; + view all
(2020)
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Multiple Sclerosis and Related Disorders
, 44
, Article 102251. 10.1016/j.msard.2020.102251.
|
Wijeratne, PA;
Johnson, EB;
Eshaghi, A;
Aksman, L;
Gregory, S;
Johnson, HJ;
Poudel, GR;
... Alexander, DC; + view all
(2020)
Robust markers and sample sizes for multi‐centre trials of Huntington's disease.
Annals of Neurology
, 87
(5)
pp. 751-762.
10.1002/ana.25709.
|
Williams, T;
Houlden, H;
Murphy, E;
John, N;
Fox, NC;
Schott, JM;
Adams, M;
... Lynch, DS; + view all
(2020)
How to diagnose difficult white matter disorders.
Practical Neurology
10.1136/practneurol-2020-002530.
(In press).
|
Williams, T;
Zetterberg, H;
Chataway, J;
(2020)
Neurofilaments in progressive multiple sclerosis: a systematic review.
Journal of Neurology
10.1007/s00415-020-09917-x.
(In press).
|
Yiannakas, MC;
Schneider, T;
Yoneyama, M;
Aforlabi-Logoh, I;
Prados, F;
Ciccarelli, O;
Wheeler-Kingshott, CAM;
(2020)
Magnetisation transfer ratio combined with magnetic resonance neurography is feasible in the proximal lumbar plexus using healthy volunteers at 3T.
Scientific Reports
, 10
, Article 14568. 10.1038/s41598-020-71570-1.
|
Zhang, L;
Tanno, R;
Xu, MC;
Jin, C;
Jacob, J;
Ciccarelli, O;
Barkhof, F;
(2020)
Disentangling human error from the ground truth in segmentation of medical images.
Advances in Neural Information Processing Systems
, 2020-D
|
Proceedings paper
Dimitrakakis, E;
Dwyer, G;
Lindenroth, L;
Aylmore, H;
Dorward, N;
Marcus, H;
Stoyanov, D;
(2020)
Towards the Development and Evaluation of a Handle Prototype for a Handheld Robotic Neurosurgical Instrument.
In:
(Proceedings) Conference on New Technologies for Computer and Robot Assisted Surgery.
CRAS
|
Grussu, F;
Blumberg, S;
Battiston, M;
Ianus, A;
Singh, S;
Gong, F;
Whitaker, H;
... Alexander, D; + view all
(2020)
SARDU-Net: a new method for model-free, data-driven experiment design in quantitative MRI.
In:
Proceedings of the International Society for Magnetic Resonance in Medicine.
(pp. p. 1035).
ISMRM
|
Zhang, L;
Tanno, R;
Bronik, K;
Jin, C;
Nachev, P;
Barkhof, F;
Ciccarelli, O;
(2020)
Learning to segment when experts disagree.
In:
Medical Image Computing and Computer Assisted Intervention – MICCAI 2020.
(pp. pp. 179-190).
Springer: Peru.
|
Working / discussion paper
Marinescu, RV;
Oxtoby, NP;
Young, AL;
Bron, EE;
Toga, AW;
Weiner, MW;
Barkhof, F;
... Alexander, DC; + view all
(2020)
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up.
ArXiv
|
Poster
Bianchi, A;
Cortese, R;
Prados, F;
Tur, C;
Kanber, B;
Yiannakas, M;
De Angelis, F;
... Toosy, A; + view all
(2020)
Optic chiasm involvement in ms, aquaporin-4 antibody-positive nmosd, and mog antibody-associated disease.
Presented at: 8th Joint ACTRIMS-ECTRIMS Meeting, Virtual conference.
|
Chataway, J;
MS-STAT2 investigators;
(2020)
MS-STAT2 trial in Secondary Progressive MS: Study design and update.
Presented at: Association of British Neurologists (ABN) Virtual Meeting 2020, Virtual conference.
|
Thesis
Collorone, Sara;
(2020)
Investigation of pathophysiological mechanisms in clinically isolated syndrome using advanced imaging techniques.
Doctoral thesis (Ph.D), UCL (University College London).
|
De Angelis, Floriana;
(2020)
Exploring Outcome Measures of disease progression in Secondary Progressive Multiple Sclerosis.
Doctoral thesis (Ph.D), UCL (University College London).
|